- €3.84bn
- €4.47bn
- €5.11bn
- 73
- 85
- 85
- 96
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 4,173 | 3,242 | 3,442 | 4,883 | 5,114 |
Cost of Revenue | |||||
Gross Profit | 738 | 608 | 837 | 1,076 | 1,594 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 4,190 | 4,245 | 3,109 | 5,004 | 4,255 |
Operating Profit | -16.9 | -1,002 | 333 | -122 | 859 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -261 | -1,229 | 138 | -233 | 793 |
Provision for Income Taxes | |||||
Net Income After Taxes | -336 | -1,325 | 36.8 | -346 | 524 |
Minority Interest | |||||
Equity in Affiliates | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -338 | -1,206 | 39.5 | -366 | 496 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -338 | -1,206 | 39.5 | -366 | 496 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -9.09 | -16.9 | 0.067 | 0.131 | 2.44 |
Dividends per Share |